Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings...
Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was in the spotlight after it rejected a second takeover bid by Cycle Group.Here's...
A regulator's decision drained the market's enthusiasm for the company.
New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted...
Stocks that traded heavily or had substantial price changes on Thursday: Accenture, KB Home rise; Snap, Jabil fall
Future Pak wants Vanda, but Vanda doesn't want Future Pak.